CME With Different Fluidic Parameters
關鍵詞
抽象
描述
Several studies have shown the adverse impact of an increase in the IOP and IOP fluctuations that occur during anterior segment intervention on the posterior segment structures. In human volunteers with each incremental increase in IOP the systolic and diastolic flow velocities in the short posterior ciliary arteries decreased linearly. This implies that the normal healthy eye is not able to autoregulate to maintain posterior ciliary artery blood flow velocities in response to acute large elevations in IOP. Vascular insufficiency due to abnormal autoregulation has been proposed as a major factor in the development of glaucoma. 1
It has been postulated that IOP elevation during the LASIK procedure causes mechanical stress which may induce tangential stress on the posterior segment.2, 3 Some studies have reported that the increase in IOP damages the retinal ganglion cells causing visual field defects. Also sudden increases in IOP, although well tolerated may induce changes in the peripheral retina.4,5,6
Several reports propose the occurrence of macular hole, lacquer cracks and choroidal neovascular membranes following the LASIK procedure. 3 It has been observed that the rapidly fluctuating pressure variations may be detrimental, particularly in susceptible persons with compromised ocular blood flow. Rapid IOP changes across a 30-mm Hg range would be predicted to influence posterior segment blood vessels.
In a previous study we compared the impact of using high fluid parameters versus low fluidic parameters on real-time IOP measured during phacoemulsification. We found that using high parameters resulted in a higher absolute rise in IOP as well as higher fluctuations in the IOP when compared to low parameters. Clinically these higher fluctuations in IOP would translate in a higher chamber instability.
We hypothesize that although transient, the increased IOP that occurs during phacoemulsification when using high parameters could cause mechanical stress on the eye. These higher fluid parameters during phacoemulsification can predispose the eye to increased macular thickness.
To the best of our knowledge there are no published data on impact of IOP changes and fluctuation that are induced during cataract surgery on the macula. To investigate this further, we decided to study the impact of using high parameters (and thus, higher chamber instability) on macular thickness following surgery, in an otherwise uncomplicated surgery.
日期
最後驗證: | 05/31/2012 |
首次提交: | 06/27/2011 |
提交的預估入學人數: | 06/28/2011 |
首次發布: | 06/29/2011 |
上次提交的更新: | 06/04/2012 |
最近更新發布: | 06/05/2012 |
實際學習開始日期: | 04/30/2010 |
預計主要完成日期: | 01/31/2011 |
預計完成日期: | 07/31/2011 |
狀況或疾病
干預/治療
Procedure: microcoaxial phacoemulsification
相
手臂組
臂 | 干預/治療 |
---|---|
Active Comparator: Longitudinal U/S - low fluidic ASPIRATION FLOW RATE - 25 CC/MIN, BOTTLE HEIGHT - 90 CMS, LONGITUDINAL ULTRASOUND | |
Active Comparator: Torsional U/S - low fluidic ASPIRATION FLOW RATE - 25 CC/MIN, BOTTLE HEIGHT - 90 CMS, TORSIONAL ULTRASOUND | |
Active Comparator: Longitudinal U/S - high fluidic ASPIRATION FLOW RATE - 40 CC/MIN, BOTTLE HEIGHT - 110 CMS, LONGITUDINAL ULTRASOUND |
資格標準
有資格學習的年齡 | 40 Years 至 40 Years |
有資格學習的性別 | All |
接受健康志願者 | 是 |
標準 | Inclusion Criteria: 1. Uncomplicated, Age-related cataract. 2. Nuclear sclerosis: upto grade 3 3. Age: 40-70 years 4. Axial length: 21.5 mm to 24.5 mm Exclusion Criteria: 1. Diabetes mellitus 2. Co-existing ocular disease- uveitis, glaucoma, PEX 3. Pre-existing macular pathology (eg.ARMD) 4. Previously operated eyes 5. Under treatment with Topical or systemic steroids / NSAID's 6. Intraoperative complications- PCR, Descemet's detachment, uveal trauma 7. Post operative complications - severe inflammation (>grade 3), rise in IOP |
結果
主要結果指標
1. cystoid macular edema (CME) [3 months]
次要成果指標
1. macular thickness [1, 3 months]
2. central corneal thickness (CCT) [first post-operative day,]
3. endothelial cell loss [6 months post-operative]
4. anterior chamber inflammation [1 months]
5. CORRECTED DISTANCE VISUAL ACUITY (CDVA) [3 months]